Stephanie Trunk’s Perspectives

310 total results. Page 18 of 26.

Health Care Counsel Blog
Reminder: Pharma Manufacturers Now Required to Report Average Sales Price (ASP) Data for Part B Drugs Via New System
Health Care Counsel Blog
Maryland’s Drug Price-Gouging Law Struck Down As Unconstitutional
Events
Lawline webinar: Pharmacy Benefit Managers
April 9, 2018
Alerts
Pharma Manufacturers Must Take Action: CMS Releases First Revised Version of the Medicaid Drug Rebate Program National Rebate Agreement Since 1991
Health Care Counsel Blog
CMS Releases First Revised Version of the Medicaid Drug Rebate Program National Rebate Agreement Since 1991
Health Care Counsel Blog
First-Of-Its-Kind Decision: Medicare Will Now Cover Certain Diagnostic Tests Utilizing Next Generation Sequencing for Cancer
Health Care Counsel Blog
Oregon Joins Growing Number of States with New Drug Pricing Transparency Laws
Health Care Counsel Blog
Providers Take Note: CMS to Hold Special Open Door Forum Related to New Medicare Cards
Health Care Counsel Blog
Some Things Never Change: Lavish Meals Result in Significant FCA Liability for Device Manufacturer
Health Care Counsel Blog
New CMS System to Report Average Sales Price (ASP) Data for Part B Drugs
Investigations Blog
Fighting the Opioid Epidemic: New DOJ Prescription Interdiction & Litigation Task Force To Target Drug Manufacturers & Distributors
Health Care Counsel Blog
Late Night Budget Bill Contains Provisions of Interest to Big Pharma